Skip to main content

Professor Norman Waugh



Professor in Public Health


WMS - Population Evidence and Technologies
University of Warwick
Tel: 02476 151585

Research Interests

Professor Waugh's interests are mainly in diabetes including studies of incidence of type 1 in children, through to mortality studies. Others interests include: - Audit studies, such as of diabetic keto-acidosis - Trials, including the REPOSE trial of insulin pumps and structured education - Health technology assessments, mainly for NICE but also for National Screening Committee and Department of Health. Recent work has included screening for hyperglycaemia in pregnancy; self-monitoring of blood gulose in people with type 2 diabetes; NICE appraisal of liraglutide for type 2, newer drugs for type 2 diabetes, ranibizumab for diabetic macular oedema. Past research experience includes cervical screening, notably the TOMBOLA trial in mild and borderline lesions


Professor Waugh graduated from Edinburgh Medical School, and did general training in anaesthetics (DA), general medicine (MRCP UK), geriatrics and general practice before doing specialist training in public health medicine (MPH and MFPHM). He became a consultant in public health Medicine in Tayside 1986 and then Grampian 1993. Several spells as acting DPH, Tayside January to April 1993, Grampian and Shetland most of 1999. While in Grampian, set up and directed the first Scottish HTA centre, SHPIC. Moved to Southampton in 2000 where directed the Southampton Health technology Assessments Centre from set-up in 2000, to departure in November 2002. Appointed prof of PHM in University of Aberdeen December 2002, and led the Aberdeen HTA Group till end March 2011. Member of NICE Appraisal Committee 2001 to 2005. Joined Warwick Evidence in June 2011.

Research Projects

View Current Projects        View All Projects


  • Johnston, Rhona, Uthman, Olalekan A., Cummins, Ewen, Clar, Christine, Royle, Pamela, Colquitt, Jill, Tan, Bee K., Clegg, Andrew, Shantikumar, Saran, Court, Rachel A., O'Hare, J., McGrane, David, Holt, Tim, Waugh, Norman, 2017. Canagliflozin, dapagliflozin and empagliflozin monotherapy for treating type 2 diabetes : systematic review and economic evaluation. Health Technology Assessment, 21 (2), pp. 1-218, View
  • Mistry, Hema, Connock, M., Pink, Joshua, Shyangdan, D. (Deepson), Clar, Christine, Royle, Pamela, Court, Rachel A., Biant, Leela C., Metcalfe, Andrew, Waugh, N., 2017. Autologous chondrocyte implantation in the knee : systematic review and economic evaluation. Health Technology Assessment, 21 (6), pp. 1-294, View
  • McFarlane, Michael, Chambers, Samantha, Malik, Ahmad, Lee, Bee, Sung, Edmond, Nwokolo, Chuka U., Waugh, Norman, Arasaradnam, Ramesh P., 2016. Clinical outcomes at 12 months and risk of inflammatory bowel disease in patients with an intermediate raised fecal calprotectin : a 'real-world' view. BMJ Open, 6 (6), pp. 1-6, View
  • Royle, Pamela, Mistry, Hema, Auguste, Peter, Shyangdan, D., Freeman, Karoline, Lois, Noemi, Waugh, Norman, 2015. Pan-retinal photocoagulation and other forms of laser treatment and drug therapies for non-proliferative diabetic retinopathy : systematic review and economic evaluation. Health Technology Assessment, 19 (51), pp. 1-248, View

View All Publications

Update your user profile on Ideate